Reported Earnings • Jul 07
Full year 2025 earnings released: R$13.57 loss per share (vs R$40.42 loss in FY 2024) Full year 2025 results: R$13.57 loss per share (improved from R$40.42 loss in FY 2024). Revenue: R$562.4m (up 22% from FY 2024). Net loss: R$1.33b (loss narrowed 38% from FY 2024). New Risk • May 28
New major risk - Market cap size The company's market capitalization is less than US$10m. Market cap: R$39.7m (US$7.84m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (14% average weekly change). Negative equity (-R$7.5b). Earnings have declined by 17% per year over the past 5 years. Shareholders have been substantially diluted in the past year (55% increase in shares outstanding). Market cap is less than US$10m (R$39.7m market cap, or US$7.84m). Announcement • Mar 31
Paranapanema S.A., Annual General Meeting, Apr 30, 2026 Paranapanema S.A., Annual General Meeting, Apr 30, 2026. Reported Earnings • Mar 30
Third quarter 2025 earnings released: R$5.24 loss per share (vs R$6.82 loss in 3Q 2024) Third quarter 2025 results: R$5.24 loss per share. Revenue: R$169.6m (up 27% from 3Q 2024). Net loss: R$371.6m (loss widened 11% from 3Q 2024). New Risk • Feb 24
New minor risk - Financial data availability The company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2025. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (18% average weekly change). Negative equity (-R$6.7b). Earnings have declined by 21% per year over the past 5 years. Shareholders have been substantially diluted in the past year (65% increase in shares outstanding). Minor Risks Latest financial reports are more than 6 months old (reported June 2025 fiscal period end). Market cap is less than US$100m (R$84.4m market cap, or US$16.4m). Board Change • Oct 01
Insufficient new directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 11 experienced directors. 1 highly experienced director. Chairman of the Board Marcelo Adilson Torresi was the last director to join the board, commencing their role in 2022. The following issues are considered to be risks according to the Simply Wall St Risk Model: Insufficient board refreshment. New Risk • Sep 23
New major risk - Shareholder dilution The company's shareholders have been substantially diluted in the past year. Increase in shares outstanding: 31% This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (8.8% average weekly change). Negative equity (-R$6.7b). Earnings have declined by 21% per year over the past 5 years. Shareholders have been substantially diluted in the past year (31% increase in shares outstanding). Minor Risk Market cap is less than US$100m (R$120.5m market cap, or US$22.6m). Reported Earnings • Aug 11
Second quarter 2025 earnings released: R$3.66 loss per share (vs R$13.54 loss in 2Q 2024) Second quarter 2025 results: R$3.66 loss per share (improved from R$13.54 loss in 2Q 2024). Revenue: R$142.7m (up 20% from 2Q 2024). Net loss: R$257.5m (loss narrowed 62% from 2Q 2024). Over the last 3 years on average, earnings per share has increased by 13% per year but the company’s share price has fallen by 44% per year, which means it is significantly lagging earnings. Announcement • Aug 05
Paranapanema S.A. to Report Q3, 2025 Results on Nov 07, 2025 Paranapanema S.A. announced that they will report Q3, 2025 results on Nov 07, 2025 Announcement • Jun 03
Paranapanema S.A. to Report Q2, 2025 Results on Aug 08, 2025 Paranapanema S.A. announced that they will report Q2, 2025 results on Aug 08, 2025 Reported Earnings • May 13
First quarter 2025 earnings released: R$1.88 loss per share (vs R$6.61 loss in 1Q 2024) First quarter 2025 results: R$1.88 loss per share (improved from R$6.61 loss in 1Q 2024). Revenue: R$134.1m (up 74% from 1Q 2024). Net loss: R$131.9m (loss narrowed 59% from 1Q 2024). Over the last 3 years on average, earnings per share has fallen by 4% per year but the company’s share price has fallen by 32% per year, which means it is performing significantly worse than earnings. Buy Or Sell Opportunity • Apr 09
Now 21% undervalued Over the last 90 days, the stock has risen 48% to R$2.03. The fair value is estimated to be R$2.58, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 78% over the last 3 years. Earnings per share has declined by 14%. New Risk • Mar 24
New major risk - Shareholder dilution The company's shareholders have been substantially diluted in the past year. Increase in shares outstanding: 33% This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (19% average weekly change). Negative equity (-R$6.3b). Earnings have declined by 30% per year over the past 5 years. Shareholders have been substantially diluted in the past year (33% increase in shares outstanding). Minor Risk Market cap is less than US$100m (R$78.4m market cap, or US$13.6m). Announcement • Mar 18
Paranapanema S.A., Annual General Meeting, Apr 16, 2025 Paranapanema S.A., Annual General Meeting, Apr 16, 2025. Location: to be held exclusively, Brazil Reported Earnings • Mar 17
Full year 2024 earnings released: R$34.35 loss per share (vs R$32.02 loss in FY 2023) Full year 2024 results: R$34.35 loss per share (further deteriorated from R$32.02 loss in FY 2023). Revenue: R$459.9m (down 53% from FY 2023). Net loss: R$2.14b (loss widened 54% from FY 2023). Over the last 3 years on average, earnings per share has fallen by 13% per year but the company’s share price has fallen by 49% per year, which means it is performing significantly worse than earnings. Buy Or Sell Opportunity • Mar 13
Now 22% undervalued Over the last 90 days, the stock has risen 8.0% to R$1.08. The fair value is estimated to be R$1.38, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 75% over the last 3 years. Earnings per share has declined by 25%. Buy Or Sell Opportunity • Feb 21
Now 20% undervalued Over the last 90 days, the stock has risen 8.9% to R$1.10. The fair value is estimated to be R$1.38, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 75% over the last 3 years. Earnings per share has declined by 25%. Buy Or Sell Opportunity • Jan 29
Now 21% undervalued Over the last 90 days, the stock has risen 11% to R$1.08. The fair value is estimated to be R$1.36, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 75% over the last 3 years. Earnings per share has declined by 25%. New Risk • Jan 16
New major risk - Shareholder dilution The company's shareholders have been substantially diluted in the past year. Increase in shares outstanding: 43% This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (21% average weekly change). Negative equity (-R$5.5b). Earnings have declined by 35% per year over the past 5 years. Shareholders have been substantially diluted in the past year (43% increase in shares outstanding). Minor Risk Market cap is less than US$100m (R$85.3m market cap, or US$14.1m). Buy Or Sell Opportunity • Jan 06
Now 26% undervalued after recent price drop Over the last 90 days, the stock has fallen 25% to R$1.01. The fair value is estimated to be R$1.36, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 75% over the last 3 years. Earnings per share has declined by 25%. New Risk • Dec 18
New major risk - Market cap size The company's market capitalization is less than US$10m. Market cap: R$61.0m (US$9.85m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (10% average weekly change). Negative equity (-R$5.5b). Earnings have declined by 35% per year over the past 5 years. Market cap is less than US$10m (R$61.0m market cap, or US$9.85m). Minor Risk Shareholders have been diluted in the past year (43% increase in shares outstanding). Reported Earnings • Dec 18
Third quarter 2024 earnings released: R$6.82 loss per share (vs R$8.81 loss in 3Q 2023) Third quarter 2024 results: R$6.82 loss per share (improved from R$8.81 loss in 3Q 2023). Revenue: R$133.5m (down 31% from 3Q 2023). Net loss: R$335.2m (loss narrowed 12% from 3Q 2023). Over the last 3 years on average, earnings per share has fallen by 25% per year but the company’s share price has fallen by 55% per year, which means it is performing significantly worse than earnings. Announcement • Dec 13
Paranapanema S.A. to Report Fiscal Year 2024 Results on Mar 14, 2025 Paranapanema S.A. announced that they will report fiscal year 2024 results on Mar 14, 2025 Buy Or Sell Opportunity • Nov 14
Now 21% undervalued after recent price drop Over the last 90 days, the stock has fallen 48% to R$1.08. The fair value is estimated to be R$1.36, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 75% over the last 3 years. Earnings per share has declined by 34%. Reported Earnings • Nov 10
Third quarter 2024 earnings released Third quarter 2024 results: Revenue: R$133.5m (down 31% from 3Q 2023). Net loss: R$335.2m (loss narrowed 12% from 3Q 2023). Over the last 3 years on average, earnings per share has fallen by 34% per year but the company’s share price has fallen by 53% per year, which means it is performing significantly worse than earnings. Announcement • Oct 24
Paranapanema S.A. to Report Q3, 2024 Results on Nov 08, 2024 Paranapanema S.A. announced that they will report Q3, 2024 results After-Market on Nov 08, 2024 Buy Or Sell Opportunity • Sep 29
Now 20% undervalued after recent price drop Over the last 90 days, the stock has fallen 31% to R$1.63. The fair value is estimated to be R$2.05, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 67% over the last 3 years. Earnings per share has declined by 41%. New Risk • Aug 23
New minor risk - Shareholder dilution The company's shareholders have been diluted in the past year. Increase in shares outstanding: 45% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Negative equity (-R$5.1b). Earnings have declined by 41% per year over the past 5 years. Minor Risks Shareholders have been diluted in the past year (45% increase in shares outstanding). Market cap is less than US$100m (R$123.6m market cap, or US$22.5m). Reported Earnings • Aug 11
Second quarter 2024 earnings released: R$13.54 loss per share (vs R$14.13 loss in 2Q 2023) Second quarter 2024 results: R$13.54 loss per share. Revenue: R$119.4m (down 55% from 2Q 2023). Net loss: R$670.8m (loss widened 9.4% from 2Q 2023). Announcement • Jul 25
Paranapanema S.A. to Report Q2, 2024 Results on Aug 09, 2024 Paranapanema S.A. announced that they will report Q2, 2024 results at 6:00 PM, E. South America Standard Time on Aug 09, 2024 Reported Earnings • May 12
First quarter 2024 earnings released: R$7.45 loss per share (vs R$4.40 loss in 1Q 2023) First quarter 2024 results: R$7.45 loss per share (further deteriorated from R$4.40 loss in 1Q 2023). Revenue: R$77.0m (down 83% from 1Q 2023). Net loss: R$323.2m (loss widened 81% from 1Q 2023). Over the last 3 years on average, earnings per share has fallen by 53% per year but the company’s share price has only fallen by 44% per year, which means it has not declined as severely as earnings. Reported Earnings • Mar 17
Full year 2023 earnings released: R$32.02 loss per share (vs R$66.36 loss in FY 2022) Full year 2023 results: R$32.02 loss per share (improved from R$66.36 loss in FY 2022). Revenue: R$972.8m (down 52% from FY 2022). Net loss: R$1.39b (loss narrowed 49% from FY 2022). Over the last 3 years on average, earnings per share has fallen by 60% per year but the company’s share price has only fallen by 27% per year, which means it has not declined as severely as earnings. Announcement • Mar 05
Paranapanema S.A. to Report Q4, 2023 Results on Mar 15, 2024 Paranapanema S.A. announced that they will report Q4, 2023 results at 6:00 PM, E. South America Standard Time on Mar 15, 2024 New Risk • Feb 26
New minor risk - Shareholder dilution The company's shareholders have been diluted in the past year. Increase in shares outstanding: 30% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Negative equity (-R$4.0b). Earnings have declined by 52% per year over the past 5 years. Minor Risks Shareholders have been diluted in the past year (30% increase in shares outstanding). Market cap is less than US$100m (R$214.5m market cap, or US$43.0m). Reported Earnings • Mar 19
Full year 2022 earnings released: R$66.36 loss per share (vs R$19.68 loss in FY 2021) Full year 2022 results: R$66.36 loss per share (further deteriorated from R$19.68 loss in FY 2021). Revenue: R$2.01b (down 57% from FY 2021). Net loss: R$2.70b (loss widened 237% from FY 2021). Over the last 3 years on average, earnings per share has fallen by 39% per year but the company’s share price has only fallen by 21% per year, which means it has not declined as severely as earnings. Reported Earnings • Nov 16
Third quarter 2022 earnings released: R$7.79 loss per share (vs R$10.31 loss in 3Q 2021) Third quarter 2022 results: R$7.79 loss per share (improved from R$10.31 loss in 3Q 2021). Revenue: R$474.5m (down 61% from 3Q 2021). Net loss: R$317.0m (loss narrowed 24% from 3Q 2021). Over the last 3 years on average, earnings per share has fallen by 27% per year but the company’s share price has fallen by 38% per year, which means it is performing significantly worse than earnings. Board Change • Nov 16
High number of new and inexperienced directors There are 8 new directors who have joined the board in the last 3 years. The company's board is composed of: 8 new directors. 1 experienced director. 1 highly experienced director. Senior Independent Director Paulo Amador Alves da Cunha Bueno is the most experienced director on the board, commencing their role in 2014. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors. Reported Earnings • Aug 16
Second quarter 2022 earnings released: R$13.82 loss per share (vs R$5.13 profit in 2Q 2021) Second quarter 2022 results: R$13.82 loss per share (down from R$5.13 profit in 2Q 2021). Revenue: R$552.0m (down 53% from 2Q 2021). Net loss: R$562.3m (down 369% from profit in 2Q 2021). Over the last 3 years on average, earnings per share has fallen by 38% per year whereas the company’s share price has fallen by 40% per year. Reported Earnings • May 01
First quarter 2022 earnings released: EPS: R$4.17 (vs R$9.88 loss in 1Q 2021) First quarter 2022 results: EPS: R$4.17 (up from R$9.88 loss in 1Q 2021). Revenue: R$812.7m (down 38% from 1Q 2021). Net income: R$169.7m (up R$572.0m from 1Q 2021). Profit margin: 21% (up from net loss in 1Q 2021). Over the last 3 years on average, earnings per share has fallen by 32% per year whereas the company’s share price has fallen by 30% per year. Board Change • Apr 26
Less than half of directors are independent There are 7 new directors who have joined the board in the last 3 years. Of these new board members, none were independent directors. The company's board is composed of: 7 new directors. 1 experienced director. 1 highly experienced director. 1 independent director (4 non-independent directors). Senior Independent Director Paulo Amador Alves da Cunha Bueno is the most experienced director on the board, commencing their role in 2014. They were also the last independent director to join the board. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Lack of board continuity. Lack of experienced directors. Reported Earnings • Nov 15
Third quarter 2021 earnings released: R$9.67 loss per share (vs R$4.08 loss in 3Q 2020) The company reported a mediocre third quarter result with increased losses and weaker control over costs, although revenues improved. Third quarter 2021 results: Revenue: R$1.21b (up 44% from 3Q 2020). Net loss: R$419.6m (loss widened 152% from 3Q 2020). Over the last 3 years on average, earnings per share has fallen by 33% per year but the company’s share price has only fallen by 26% per year, which means it has not declined as severely as earnings. Reported Earnings • Jul 31
Second quarter 2021 earnings released: EPS R$4.81 (vs R$6.79 loss in 2Q 2020) The company reported a strong second quarter result with improved earnings, revenues and profit margins. Second quarter 2021 results: Revenue: R$1.16b (up 6.8% from 2Q 2020). Net income: R$208.9m (up R$485.4m from 2Q 2020). Profit margin: 18% (up from net loss in 2Q 2020). Over the last 3 years on average, earnings per share has fallen by 34% per year but the company’s share price has only fallen by 12% per year, which means it has not declined as severely as earnings. Reported Earnings • May 05
First quarter 2021 earnings released: R$9.27 loss per share (vs R$14.00 loss in 1Q 2020) The company reported a solid first quarter result with reduced losses, improved revenues and improved control over expenses. First quarter 2021 results: Revenue: R$1.31b (up 44% from 1Q 2020). Net loss: R$402.3m (loss narrowed 29% from 1Q 2020). Over the last 3 years on average, earnings per share has fallen by 48% per year but the company’s share price has only fallen by 4% per year, which means it has not declined as severely as earnings. Is New 90 Day High Low • Mar 09
New 90-day low: R$8.59 The company is down 19% from its price of R$10.57 on 08 December 2020. The Brazilian market is up 1.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Metals and Mining industry, which is up 21% over the same period. Reported Earnings • Mar 07
Full year 2020 earnings released: R$21.17 loss per share (vs R$0.62 loss in FY 2019) The company reported a poor full year result with increased losses, weaker revenues and weaker control over costs. Full year 2020 results: Revenue: R$4.29b (down 18% from FY 2019). Net loss: R$861.6m (loss widened R$836.5m from FY 2019). Over the last 3 years on average, earnings per share has fallen by 49% per year but the company’s share price has only fallen by 30% per year, which means it has not declined as severely as earnings. Announcement • Mar 07
Paranapanema S.A. to Report Q1, 2021 Results on Apr 29, 2021 Paranapanema S.A. announced that they will report Q1, 2021 results After-Market on Apr 29, 2021 Announcement • Mar 06
Paranapanema S.A., Annual General Meeting, Apr 29, 2021 Paranapanema S.A., Annual General Meeting, Apr 29, 2021, at 08:00 US Eastern Standard Time. Announcement • Feb 18
Paranapanema S.A. to Report Q4, 2020 Results on Mar 04, 2021 Paranapanema S.A. announced that they will report Q4, 2020 results After-Market on Mar 04, 2021 Is New 90 Day High Low • Jan 15
New 90-day low: R$9.29 The company is down 18% from its price of R$11.30 on 16 October 2020. The Brazilian market is up 22% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Metals and Mining industry, which is up 55% over the same period. Is New 90 Day High Low • Dec 03
New 90-day high: R$12.46 The company is up 7.0% from its price of R$11.69 on 04 September 2020. The Brazilian market is up 9.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Metals and Mining industry, which is up 34% over the same period. Is New 90 Day High Low • Oct 29
New 90-day low: R$9.53 The company is down 26% from its price of R$12.90 on 31 July 2020. The Brazilian market is down 5.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Metals and Mining industry, which is up 9.0% over the same period. Announcement • Oct 06
Paranapanema S.A. to Report Q3, 2020 Results on Nov 03, 2020 Paranapanema S.A. announced that they will report Q3, 2020 results on Nov 03, 2020 Is New 90 Day High Low • Sep 19
New 90-day low: R$11.06 The company is down 20% from its price of R$13.80 on 19 June 2020. The Brazilian market is up 3.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Metals and Mining industry, which is up 18% over the same period.